Literature DB >> 17717917

[Study on the quantitative evaluation on the degree of TCM basic syndromes often encountered in patients with primary liver cancer].

Dong-tao Li1, Chang-quan Ling, De-zeng Zhu.   

Abstract

OBJECTIVE: To establish a quantitative model for evaluating the degree of the TCM basic syndromes often encountered in patients with primary liver cancer (PLC).
METHODS: Medical literatures concerning the clinical investigation and TCM syndrome of PLC were collected and analyzed adopting expert-composed symposium method, and the 100 millimeter scaling was applied in combining with scoring on degree of symptoms to establish a quantitative criterion for symptoms and signs degree classification in patients with PLC. Two models, i.e. the additive model and the additive-multiplicative model, were established by using comprehensive analytic hierarchy process (AHP) as the mathematical tool to estimate the weight of the criterion for evaluating basic syndromes in various layers by specialists. Then the two models were verified in clinical practice and the outcomes were compared with that fuzzy evaluated by specialists.
RESULTS: Verification on 459 times/case of PLC showed that the coincidence rate between the outcomes derived from specialists with that from the additive model was 84.53 %, and with that from the additive-multificative model was 62.75 %, the difference between the two showed statistical significance (P<0.01).
CONCLUSIONS: It could be decided that the additive model is the principle model suitable for quantitative evaluation on the degree of TCM basic syndromes in patients with PLC.

Entities:  

Mesh:

Year:  2007        PMID: 17717917

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  3 in total

1.  Metabolic profiling study of yang deficiency syndrome in hepatocellular carcinoma by h1 NMR and pattern recognition.

Authors:  Xueqiang Huang; Qunwei Chen; Genjin Yang; Weixing Dai; Qingbo Lang; Juan Du; Shikai Yan; Weidong Zhang; Changquan Ling
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-27       Impact factor: 2.629

2.  Study on TCM Syndrome Differentiation of Primary Liver Cancer Based on the Analysis of Latent Structural Model.

Authors:  Zhan Gu; Xiuzhong Qi; Xiaofeng Zhai; Qingbo Lang; Jianying Lu; Changping Ma; Long Liu; Xiaoqiang Yue
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-01       Impact factor: 2.629

3.  Computational and In Vitro Analysis of Plumbagin's Molecular Mechanism for the Treatment of Hepatocellular Carcinoma.

Authors:  Yanfei Wei; Yuning Lin; Wanjun Chen; Shasha Liu; Lijie Jin; Delun Huang
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.